Indivior PLC J.P. Morgan Healthcare Conference (8852A)
05 January 2018 - 12:00AM
UK Regulatory
TIDMINDV
RNS Number : 8852A
Indivior PLC
04 January 2018
Indivior's Shaun Thaxter to Present at the 36th Annual
J.P. Morgan Healthcare Conference on January 11th
Slough, UK, and Richmond, VA, 4th January 2018 - Indivior PLC
(LON: INDV) today announced that Shaun Thaxter, CEO, will present
at the 36th Annual J.P. Morgan Healthcare Conference on January
11th, 2018, at 8:30 a.m. local Pacific time (11:30 a.m. Eastern /
4:30 p.m. GMT) from the Westin St. Francis Hotel in San Francisco.
Mark Crossley, CFO, and Jason Thompson, VP of Investor Relations,
will also be in attendance. Thaxter will review Indivior's business
and outlook. The presentation will be webcast live and, along with
the presentation materials, will be available to the public on the
"Investors" section of Indivior's website (www.indivior.com).
About Indivior
Indivior is a global specialty pharmaceutical company with a
20-year legacy of leadership in patient advocacy and health policy
while providing education on evidence-based treatment models that
have revolutionized modern addiction treatment. The name is the
fusion of the words individual and endeavour, and the tagline
"Focus on you" makes the Company's commitment clear. Indivior is
dedicated to transforming addiction from a global human crisis to a
recognized and treated chronic disease. Building on its global
portfolio of opioid dependence treatments, Indivior has a strong
pipeline of product candidates designed to both expand on its
heritage in this category and address other chronic conditions and
co-occurring disorders of addiction, including alcohol use disorder
and schizophrenia. Headquartered in the United States in Richmond,
VA, Indivior employs more than 900 individuals globally and its
portfolio of products is available in over 40 countries worldwide.
Visit www.indivior.com to learn more.
Contact:
Jason Thompson
Vice President, Investor Relations
Tel: 804-423-8916 or jason.thompson@indivior.com
This information is provided by RNS
The company news service from the London Stock Exchange
END
MSCEXLFBVFFBBBV
(END) Dow Jones Newswires
January 04, 2018 08:00 ET (13:00 GMT)
Indivior (LSE:INDV)
Historical Stock Chart
From Apr 2024 to May 2024
Indivior (LSE:INDV)
Historical Stock Chart
From May 2023 to May 2024
